Risk of recurrent venous thromboembolism (VTE) in patients with chronic kidney disease (CKD) and VTE was significantly reduced in those who were treated with apixaban vs warfarin, investigators ...

For patients with cirrhosis and nonvalvular atrial fibrillation (AF), initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage, according to a study ...

In the absence of head-to-head trials, real-world data may help inform treatment decisions. Rates of major bleeding are lower with apixaban compared with rivaroxaban or warfarin in patients with ...

Please provide your email address to receive an email when new articles are posted on . Prescriptions dispensed for apixaban beyond 90 days after hospitalization resulted in a lower rate of ...

Please provide your email address to receive an email when new articles are posted on . For patients with non-valvular atrial fibrillation, study results showed treatment with apixaban was associated ...

For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban. Data remain inconclusive regarding ...

In older patients with atrial fibrillation (AF), apixaban seems to improve outcomes relative to warfarin regardless of frailty status, whereas other direct oral anticoagulants (DOACs) appear ...

Apixaban is a direct oral anticoagulant that relies less on kidney excretion. Compared with warfarin, apixaban may lower the risks of recurrent venous thromboembolism (VTE) and major bleeding in ...

BACKGROUND: Direct oral anticoagulants such as apixaban and rivaroxaban, have transformed the management of thromboembolic ...

Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study.

Are frail older adults with atrial fibrillation (AF) better off sticking with warfarin, the tried-and-true vitamin K antagonist? Maybe not, according to new data in the Journal of the American College ...